Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses —241.39 K575.47 K224 K181.09 K240.08 K 1.22 M Research & development —————— — Operating income —-241.39 K-575.47 K-224 K-181.09 K-240.08 K -1.22 M Non-Operating Income, Total —1.22 M1.22 M1.24 M1.15 M1.06 M 4.67 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses —1.22 M1.22 M1.24 M1.15 M1.06 M 4.67 M Unusual income/expense —————— — Pretax income —974.31 K645.82 K1.01 M972.67 K821.71 K 3.45 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations —974.31 K645.82 K1.01 M972.67 K821.71 K 3.45 M Discontinued operations —————— — Net income —974.31 K645.82 K1.01 M972.67 K821.71 K 3.45 M Dilution adjustment —————1.06 M — Preferred dividends —————1.06 M — Diluted net income available to common stockholders —974.31 K645.82 K1.01 M972.67 K821.71 K 3.45 M Basic earnings per share (Basic EPS) —0.120.080.140.120.1 0.44 Diluted earnings per share (Diluted EPS) —0.120.080.140.120.1 0.44 Average basic shares outstanding 6 M15.92 M15.92 M15.92 M15.92 M15.92 M — Diluted shares outstanding 6 M15.92 M15.92 M15.92 M15.92 M15.92 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —